NXPL · NextPlat Corp · Short Interest
The latest filing states the doubt was alleviated.
“These conditions raised substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance of these Condensed Consolidated Financial Statements. Management has evaluated its plans to mitigate these conditions. These plans include expanding the Company's long-term care pharmacy operations, increasing 340B contract pharmacy revenue, developing additional institutional medication fulfillment contracts, and implementing identified operational efficiencies. For the six months ended June 30, 2026, operating loss decreased to approximately $1.2 million from $3.9 million, and cash used in operating activities decreased to approximately $1.5 million from $3.1 million. As of June 30, 2026, the Company had cash of approximately $11.9 million and $3.8 million of remaining availability under the ATM Program. Based on these results, management's projections of operating results and cash flows for the twelve months following issuance, and the Company's liquidity position, management has concluded that its plans, which are probable of being effectively implemented and probable of mitigating the relevant conditions, alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
NXPL Latest Reported Short Interest
FINRA reported 5,690 NXPL shares sold short as of the October 30, 2026 settlement date, an increase of 120 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
Positioning score 28.0 + catalyst boost 10 (total capped at 100). This is a screening index, not a probability of a squeeze.
Method and coverage limits
Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.
Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.
The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.
Options positioning & squeeze sensitivity
Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.
No active listed options were found.
Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.
Assessment prepared 2026-11-13 09:05 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-11-30
Scheduled
FINRA publishes Dec 9
|
— | — | — | — |
|
2026-11-13
Scheduled
FINRA publishes Nov 24
|
— | — | — | — |
| 2026-10-30 | 5,690 | 5,570 | +120 | 1.00 |
| 2026-10-15 | 5,570 | 2,954 | +2,616 | 1.00 |
| 2026-09-30 | 2,954 | 3,291 | -337 | 1.00 |
| 2026-09-15 | 3,291 | 5,222 | -1,931 | 1.00 |
| 2026-08-31 | 5,222 | 4,431 | +791 | 1.00 |
| 2026-08-14 | 4,431 | 6,288 | -1,857 | 1.00 |
| 2026-07-31 | 6,288 | 5,209 | +1,079 | 1.00 |
| 2026-07-15 | 5,209 | 7,645 | -2,436 | 1.00 |
| 2026-06-30 | 7,645 | 11,956 | -4,311 | 1.00 |
| 2026-06-15 | 11,956 | 33,021 | -21,065 | 1.00 |
| 2026-05-29 | 33,021 | 35,131 | -2,110 | 1.26 |
| 2026-05-15 | 35,131 | 30,154 | +4,977 | 4.21 |
| 2026-04-30 | 30,154 | 33,982 | -3,828 | 2.00 |
| 2026-04-15 | 33,982 | 24,613 | +9,369 | 1.22 |
| 2026-03-31 | 24,613 | 95,504 | -70,891 | 1.00 |
| 2026-03-13 | 95,504 | 51,828 | +43,676 | 1.00 |
| 2026-02-27 | 51,828 | 15,829 | +35,999 | 1.00 |
| 2026-02-13 | 15,829 | 18,671 | -2,842 | 2.73 |
| 2026-01-30 | 18,671 | 19,641 | -970 | 5.99 |
| 2026-01-15 | 19,641 | 14,635 | +5,006 | 2.33 |
| 2025-12-31 | 14,635 | 19,911 | -5,276 | 1.00 |
| 2025-12-15 | 19,911 | 29,487 | -9,576 | 1.00 |
| 2025-11-28 | 29,487 | 52,902 | -23,415 | 3.20 |
| 2025-11-14 | 52,902 | 102,307 | -49,405 | 1.61 |
Full FINRA short interest reporting calendar